Pediatrix CFO awarded 31,800 restricted shares

Pediatrix Medical Group EVP, CFO and Treasurer Kasandra H. Rossi received 31,800 restricted shares of common stock as an annual equity award under the company’s incentive compensation plan.

Rhea-AI Filing Summary

Pediatrix Medical Group EVP, CFO and Treasurer Kasandra H. Rossi received 31,800 restricted shares of common stock as an annual equity award under the company’s incentive compensation plan. The award vests 25% on June 1, 2027, 25% on June 1, 2028, and 50% on June 1, 2029. In connection with vesting of prior awards, 3,701 restricted shares were withheld to cover taxes. After these transactions, Rossi directly holds 101,399 common shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Rossi Kasandra H

Role EVP, CFO and Treasurer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	31,800	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,701	$21.54	$80K

Holdings After Transaction: Common Stock — 101,399 shares (Direct)

Footnotes (2)

1. F1. Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.
2. F2. Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares.

Key Figures

Restricted stock grant: 31,800 shares Tax-withheld shares: 3,701 shares Price used for tax withholding: $21.54 per share +4 more

7 metrics

Restricted stock grant 31,800 shares Annual equity award to EVP, CFO and Treasurer

Tax-withheld shares 3,701 shares Restricted shares withheld to pay taxes on vesting

Price used for tax withholding $21.54 per share Value applied to 3,701 withheld shares

Post-transaction holdings 105,100 shares Common shares directly held after transactions

Pre-grant holdings snapshot 101,399 shares Total shares following tax-withholding transaction

Tax-withholding disposition Code F Payment of tax liability by delivering securities

Equity grant code Code A Grant, award, or other acquisition of common stock

Key Terms

Restricted shares, Second Amended and Restated 2008 Incentive Compensation Plan, tax-withholding disposition, grant, award, or other acquisition

4 terms

Restricted shares financial

"Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Second Amended and Restated 2008 Incentive Compensation Plan financial

"granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan")"

tax-withholding disposition financial

"Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

grant, award, or other acquisition financial

"Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Pediatrix (MD) report for Kasandra H. Rossi?

Pediatrix reported that EVP and CFO Kasandra H. Rossi received a grant of 31,800 restricted common shares and had 3,701 restricted shares withheld to cover taxes on vesting, leaving her with 105,100 directly held common shares after these transactions.

How many Pediatrix (MD) shares were granted to the EVP and CFO?

Kasandra H. Rossi received a grant of 31,800 restricted shares of Pediatrix common stock. These shares were awarded under the company’s Second Amended and Restated 2008 Incentive Compensation Plan as part of her annual equity award, subject to a multi-year vesting schedule.

What is the vesting schedule for the 31,800 restricted Pediatrix (MD) shares?

The 31,800 restricted shares vest in three stages: 25% on June 1, 2027, another 25% on June 1, 2028, and the remaining 50% on June 1, 2029. Vesting is subject to the terms and conditions of Pediatrix’s incentive compensation plan.

Why were 3,701 Pediatrix (MD) shares disposed of in this Form 4?

The 3,701 shares were withheld to pay taxes triggered by the vesting of restricted stock. This tax-withholding disposition is a non-market transaction where shares are retained by the issuer to satisfy tax obligations rather than being sold in the open market.

How many Pediatrix (MD) shares does Kasandra H. Rossi hold after these transactions?

Following the grant and tax-withholding disposition, Kasandra H. Rossi directly holds 105,100 Pediatrix common shares. This total reflects her updated ownership position after receiving 31,800 restricted shares and having 3,701 restricted shares withheld for tax payments.

Under which plan were the new Pediatrix (MD) restricted shares granted?

The 31,800 restricted shares were granted under Pediatrix’s Second Amended and Restated 2008 Incentive Compensation Plan. This plan governs equity-based awards, including restricted stock, and sets the vesting terms and conditions for executive compensation grants like this one.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rossi Kasandra H

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FLORIDA 33323

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO and Treasurer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A(1)		31,800	A	$0	105,100	D
Common Stock	06/01/2026		F(2)		3,701	D	$21.54	101,399	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

2. Represents 3,701 restricted shares withheld for payment of taxes upon vesting of shares.

	/s/ Mary Ann E. Moore, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)